Functional Dyspepsia in Review: Pathophysiology and Challenges in the Diagnosis and Management due to Coexisting Gastroesophageal Reflux Disease and Irritable Bowel Syndrome
- PMID: 23762034
- PMCID: PMC3670552
- DOI: 10.1155/2013/351086
Functional Dyspepsia in Review: Pathophysiology and Challenges in the Diagnosis and Management due to Coexisting Gastroesophageal Reflux Disease and Irritable Bowel Syndrome
Abstract
Functional dyspepsia is a common disorder which imposes significant diagnostic and treatment challenges for patients and physicians. The most recent update of the diagnostic criteria subdivides functional dyspepsia into two subcategories based on the main symptom of epigastric pain or postmeal fullness. As we discuss in this review, several studies have shown significant overlap in symptoms and pathophysiology between functional dyspepsia, irritable bowel syndrome, and the spectrum of reflux disorders. This overlap in symptoms can be informative in helping us to understand the underlying pathophysiology, diagnostic approaches, and treatment strategies. The addition of diagnostic testing such as pH impedance manometry of the distal esophagus to the current common diagnostic tests might be helpful in distinguishing between functional dyspepsia and reflux disease. Importantly, various treatment modalities may be more effective than others if the main symptom is burning rather than pain or postmeal fullness rather than early satiation.
Figures

Similar articles
-
Prevalence and symptom pattern of pathologic esophageal acid reflux in patients with functional dyspepsia based on the Rome III criteria.Am J Gastroenterol. 2010 Dec;105(12):2626-31. doi: 10.1038/ajg.2010.351. Epub 2010 Sep 7. Am J Gastroenterol. 2010. PMID: 20823838
-
Impact of coexisting irritable bowel syndrome and non-erosive reflux disease on postprandial abdominal fullness and sleep disorders in functional dyspepsia.J Nippon Med Sch. 2013;80(5):362-70. doi: 10.1272/jnms.80.362. J Nippon Med Sch. 2013. PMID: 24189354
-
The Therapeutic and Diagnostic Value of 2-week High Dose Proton Pump Inhibitor Treatment in Overlapping Non-erosive Gastroesophageal Reflux Disease and Functional Dyspepsia Patients.J Neurogastroenterol Motil. 2012 Apr;18(2):174-80. doi: 10.5056/jnm.2012.18.2.174. Epub 2012 Apr 9. J Neurogastroenterol Motil. 2012. PMID: 22523726 Free PMC article.
-
Dyspepsia of unknown origin: pathophysiology, diagnosis, and treatment.Dig Dis. 1997 Nov-Dec;15(6):316-29. doi: 10.1159/000171608. Dig Dis. 1997. PMID: 9439897 Review.
-
Update on the evaluation and management of functional dyspepsia.Am Fam Physician. 2011 Mar 1;83(5):547-52. Am Fam Physician. 2011. PMID: 21391521 Review.
Cited by
-
Reduced excitatory neurotransmitter levels in anterior insulae are associated with abdominal pain in irritable bowel syndrome.Pain. 2019 Sep;160(9):2004-2012. doi: 10.1097/j.pain.0000000000001589. Pain. 2019. PMID: 31045748 Free PMC article.
-
Overlap of Dyspepsia in Patients with Gastroesophageal Reflux Disease: Impact of Clinical, Metabolic, and Psychosocial Characteristics.Dig Dis Sci. 2017 Apr;62(4):994-1001. doi: 10.1007/s10620-017-4455-8. Epub 2017 Jan 23. Dig Dis Sci. 2017. PMID: 28116594
-
Common Mechanism of Pathogenesis in Gastrointestinal Diseases Implied by Consistent Efficacy of Single Chinese Medicine Formula: A PRISMA-Compliant Systematic Review and Meta-Analysis.Medicine (Baltimore). 2015 Jul;94(27):e1111. doi: 10.1097/MD.0000000000001111. Medicine (Baltimore). 2015. PMID: 26166106 Free PMC article.
-
Clinical Trial: Efficacy of Mosapride Controlled-release and Nortriptyline in Patients With Functional Dyspepsia: A Multicenter, Double-placebo, Double-blinded, Randomized Controlled, Parallel Clinical Study.J Neurogastroenterol Motil. 2024 Jan 30;30(1):106-115. doi: 10.5056/jnm23147. J Neurogastroenterol Motil. 2024. PMID: 38173162 Free PMC article.
-
Research progress of treatment of functional dyspepsia with traditional Chinese medicine compound based on cell signal pathway.Front Pharmacol. 2023 Jan 9;13:1089231. doi: 10.3389/fphar.2022.1089231. eCollection 2022. Front Pharmacol. 2023. PMID: 36699059 Free PMC article. Review.
References
-
- Xiao YL, Peng S, Tao J, et al. Prevalence and symptom pattern of pathologic esophageal acid reflux in patients with functional dyspepsia based on the Rome III criteria. American Journal of Gastroenterology. 2010;105(12):2626–2631. - PubMed
-
- Ohara S, Kawano T, Kusano M, Kouzu T. Survey on the prevalence of GERD and FD based on the Montreal definition and the Rome III criteria among patients presenting with epigastric symptoms in Japan. Journal of Gastroenterology. 2011;46(5):603–611. - PubMed
-
- Drossman DA. Introduction. The Rome Foundation and Rome III. Neurogastroenterology & Motility. 2007;19(10):783–786. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials